Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study
- DOI
- 10.1186/s12885-025-13978-4
- Published
- 2025-04-03
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-025-13978-4,
title = {Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study},
author = {Jun Xu and Junjun Li and Tengfei Wang and Xin Luo and Zhangxiang Zhu and Yimou Wang and Yong Wang and Zhenglin Zhang and Ruipeng Song and Li-Zhuang Yang and Hongzhi Wang and Stephen T. C. Wong and Hai Li},
year = {2025},
journal = {BMC Cancer},
doi = {10.1186/s12885-025-13978-4},
url = {https://doi.org/10.1186/s12885-025-13978-4}
}RIS
TY - JOUR TI - Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study AU - Jun Xu AU - Junjun Li AU - Tengfei Wang AU - Xin Luo AU - Zhangxiang Zhu AU - Yimou Wang AU - Yong Wang AU - Zhenglin Zhang AU - Ruipeng Song AU - Li-Zhuang Yang AU - Hongzhi Wang AU - Stephen T. C. Wong AU - Hai Li PY - 2025 JO - BMC Cancer DO - 10.1186/s12885-025-13978-4 UR - https://doi.org/10.1186/s12885-025-13978-4 ER -
APA
Xu, J., Li, J., Wang, T., Luo, X., Zhu, Z., Wang, Y., Wang, Y., Zhang, Z., Song, R., Yang, L., Wang, H., Wong, S. T. C., & Li, H. (2025). Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study. BMC Cancer. https://doi.org/10.1186/s12885-025-13978-4
Source records
- crossref · retrieved 2026-09-26T06:13:01.764Z